Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Qingru Zhou
Institutions:
Sun Yat-sen University,
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China,
Zhejiang University of Technology
Observed institutions:
Sun Yat-sen University,
Zhengzhou University,
Cangzhou Central Hospital,
Henan Provincial People's Hospital,
Sun Yat-sen University Cancer Center,
Henan Provincial Eye Hospital,
State Key Laboratory of Oncology in South China,
Zhejiang University of Technology
show all 8
ORCID:
0009-0009-4701-3291
Observed ORCID:
0009-0009-4701-3291
OpenAlex ID:
A5069197093
Superoxide dismutase 2 ameliorates mitochondrial dysfunction in skin fibroblasts of Leber’s hereditary optic neuropathy patients
2022
·
Qingru Zhou
, Shun Yao
, et al.
·
Frontiers in Neuroscience
·
16
PDF
Electrolyte‐Induced Interfacial/Bulk Dual Regulation Enables Negligible Capacity Decay in Li‐Rich Cathodes
2026
·
Tianqi Yang
, Min Jiang
, et al.
·
Advanced Materials
·
13
LINCS Dataset-Based Repositioning of Dutasteride as an Anti-Neuroinflammation Agent
2021
·
Dan Luo
, Lu Han
, et al.
·
Brain Sciences
·
11
PDF
A versatile sulfolane-based weakly solvated electrolyte designed for high-safety and high-voltage sodium metal batteries
2025
·
Yini Yan
, Tianqi Yang
, et al.
·
Chemical Engineering Journal
·
10
Multi-mtDNA Variants May Be a Factor Contributing to Mitochondrial Function Variety in the Skin-Derived Fibroblasts of Leber's Hereditary Optic Neuropathy Patients
2022
·
Shun Yao
, Qingru Zhou
, et al.
·
Frontiers in Molecular Neuroscience
·
7
PDF
Advances in research on Leber's hereditary optic neuropathy
2024
·
Qingru Zhou
, Zhenhui Liu
, et al.
·
Ocular genetics and omics.
·
4
Sintilimab plus eribulin and carboplatin in patients with metastatic triple-negative breast cancer (SECURE): a phase II, multicenter trial
2026
·
Mengqian Ni
, Lijia Zhou
, et al.
·
Journal for ImmunoTherapy of Cancer
Germline Pathogenic Variants in HER2 ‐Positive Breast Cancer: Spectrum and Clinical Implications in a High‐Risk Chinese Cohort
2026
·
Lijia Zhou
, Mengqian Ni
, et al.
·
Cancer Medicine
Efficacy and safety of trastuzumab deruxtecan in HR-negative HER2-low advanced breast cancer: A real-world, retrospective study.
2025
·
Mengqian Ni
, Guorong Zou
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
9
Citation count:
61
H-index:
5
I10-index:
4
Year
Topic
Type